剂量效应网络荟萃分析模型在抗抑郁药研究中的应用
A dose-effect network meta-analysis model: an application in antidepressants
摘要:
网络荟萃分析(NMA)已被用于回答一系列关于给定条件下最佳干预措施的临床问题。虽然药物的有效性和安全性取决于给药剂量,但NMA应用通常忽略药物剂量对结果的作用。这导致网络中的异质性增加。在本文中,我们提出了一套网络荟萃分析模型,采用限制三次样条(RCS)的剂量效应关系(DE-NMA)。我们将该模型扩展为剂量效应网络元回归,以考虑研究水平的协变量和类效应DE-NMA模型中的药物组。我们将这些模型应用于一个关于21种抗抑郁药和安慰剂对抑郁症疗效的汇总数据网络。我们发现,在一定剂量后,所有抗抑郁药都比安慰剂更有效。我们还确定了每种抗抑郁药作用超过安慰剂的剂量水平,并估计超过抗抑郁药作用的剂量不再增加。具有RCS的DE-NMA模型采用灵活的方法对多种干预措施中的剂量-效应关系进行建模,因此决策者可以使用它们来告知治疗选择。
英文摘要:
Network meta-analysis (NMA) has been used to answer a range of clinical questions about the preferable intervention for a given condition. Although the effectiveness and safety of pharmacological agents depend on the dose administered, NMA applications typically ignore the role that drugs dosage play on the results. This leads to more heterogeneity in the network. In this paper we present a suite of network meta-analysis models that incorporates the dose-effect relationship (DE-NMA) using restricted cubic splines (RCS). We extend the model into a dose-effect network meta-regression to account for study-level covariates and for groups of agents in a class-effect DE-NMA model. We apply the models to a network of aggregate data about the efficacy of 21 antidepressants and placebo for depression. We found that all antidepressants are more efficacious than placebo after a certain dose. We also identify the dose level in which each antidepressant effect exceeds that of placebo and estimate the dose beyond the effect of the antidepressants no longer increases. The DE-NMA model with RCS takes a flexible approach to modelling the dose-effect relationship in multiple interventions, so decision-makers can use them to inform treatment choice.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。